Skip to main content
OPKO Health Inc. logo

OPKO Health Inc. — Investor Relations & Filings

Ticker · OPK ISIN · US68375N1037 LEI · 529900A4S2D4OGOJLL02 TA Human health and social work activities
Open in API
Filings indexed 3,780 across all filing types
Latest filing 2025-04-02 Director's Dealing
Country US United States of America
Listing TA OPK

About OPKO Health Inc.

https://www.opko.com

OPKO Health, Inc. is a fully-integrated healthcare company operating in both pharmaceuticals and diagnostics. Its pharmaceutical division develops and commercializes novel therapies for serious diseases. Key marketed products include NGENLA™, a long-acting treatment for pediatric growth hormone deficiency partnered with Pfizer, and RAYALDEE®. The company's research focuses on advancing multispecific therapies for cancers and infectious diseases. Through its subsidiary, BioReference Laboratories, OPKO operates one of the largest full-service clinical reference laboratories in the U.S., providing comprehensive diagnostic testing services to millions of patients annually.

Recent filings

Filing Released Lang Actions
Form4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Phillip Frost, M.D., ET AL
Director's Dealing Classification · 99% confidence The document text explicitly contains the header "FORM 4" and "STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES". Form 4 is the standard SEC filing used to report changes in beneficial ownership of securities by company insiders (directors, officers, or 10% owners) pursuant to Section 16(a) of the Securities Exchange Act of 1934. This filing type is specifically related to insider transactions, which aligns with the definition for Director's Dealing (DIRS). Although the document details transactions, it is a specific regulatory form, not a general announcement (RPA/RNS) or a general report (10-K/IR).
2025-04-02 English
Form4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Phillip Frost, M.D., ET AL
Report Publication Announcement Classification · 98% confidence The document is a short filing (1768 chars) submitted to the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). It explicitly states, "Attached hereto is a report on *Interested party transaction*" and references a PDF file. This structure—a brief announcement pointing to an attached, specific report—fits the definition of a Report Publication Announcement (RPA). While the content relates to a specific transaction, the document itself is the notification of publication, not the full transaction report or a standard regulatory form like 10-K or IR. Therefore, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule.
2025-04-02 English
Form 8-K-OPKO entered into an additional exchange agreements pursuant to which noteholders have agreed to exchange notes for shares and cash.
Regulatory Filings Classification · 98% confidence The document explicitly identifies itself as a "FORM 8-K" and a "CURRENT REPORT" filed pursuant to the Securities Exchange Act of 1934. Form 8-K reports major events that shareholders should know about promptly. The content details an entry into a material definitive agreement (Item 1.01) regarding the exchange of convertible senior notes for common stock and cash, which constitutes a significant capital/financing activity and an unregistered sale of equity securities (Item 3.02). While the content relates to capital structure changes (CAP) or unregistered sales, the overarching regulatory filing type for a Form 8-K that reports material definitive agreements is generally classified under the broader regulatory filing category if a more specific one isn't available or if the filing itself is the primary document type being reported. However, given the specific definitions provided, the core event is a financing/capital structure change (CAP) or a general regulatory filing (RNS). Since Form 8-K is a standard SEC filing that doesn't map directly to the provided list (like 10-K or DEF 14A), and it reports a specific material event (debt-for-equity swap), it fits best under the general 'Regulatory Filings' (RNS) as a catch-all for SEC filings not explicitly listed, or potentially 'CAP' due to the nature of the transaction. Given the structure of the provided codes, RNS is the most appropriate fallback for a standard SEC Current Report (8-K) that isn't a primary financial statement report.
2025-04-02 English
Form 8-K-OPKO entered into an additional exchange agreements pursuant to which noteholders have agreed to exchange notes for shares and cash.
Report Publication Announcement Classification · 98% confidence The document is a short filing (1994 characters) issued by OPKO HEALTH, INC. It is an 'Immediate Report' filed with the Israel Securities Authority and the Tel Aviv Stock Exchange. Crucially, the text states: 'Attached hereto is a report on *Form 8-K OPKO entered into an additional exchange agreements pursuant to which noteholders have agreed to exchange notes for shares and cash.*' and lists an attached PDF file. This structure—a brief announcement referencing an attached, more detailed regulatory document (Form 8-K)—fits the definition of a Report Publication Announcement (RPA). It is not the full 8-K itself, but the notice of its publication.
2025-04-02 English
Form4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Phillip Frost, M.D., ET AL
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "FORM 4" and "STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES". Form 4 is the standard SEC filing used to report changes in beneficial ownership of securities by company insiders (directors, officers, or 10% owners) pursuant to Section 16(a) of the Securities Exchange Act of 1934. This directly corresponds to the definition of Director's Dealing (insider trades). Although the filing involves directors and officers, the specific SEC form name (Form 4) is the most precise identifier, mapping to the 'DIRS' code.
2025-03-29 English
Form4- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES- Phillip Frost, M.D., ET AL
Report Publication Announcement Classification · 98% confidence The document is an 'Immediate Report' filed with the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE). The content explicitly states: 'Attached hereto is a report on *Interested party transaction* *20250329Form4_isa.pdf*'. This structure—a brief announcement stating that a specific report (in this case, related to an interested party transaction) is attached or published—fits the definition of a Report Publication Announcement (RPA) according to Rule 2 ('MENU VS MEAL' rule). It is not the full transaction report itself, but the notification of its release. The document length (1768 chars) is very short, supporting the RPA classification over a detailed filing like 10-K or AR.
2025-03-29 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.